P Dombernowsky

8.5k total citations
195 papers, 6.7k citations indexed

About

P Dombernowsky is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, P Dombernowsky has authored 195 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Oncology, 51 papers in Pulmonary and Respiratory Medicine and 49 papers in Epidemiology. Recurrent topics in P Dombernowsky's work include Lung Cancer Research Studies (63 papers), Neuroendocrine Tumor Research Advances (48 papers) and Cancer Treatment and Pharmacology (39 papers). P Dombernowsky is often cited by papers focused on Lung Cancer Research Studies (63 papers), Neuroendocrine Tumor Research Advances (48 papers) and Cancer Treatment and Pharmacology (39 papers). P Dombernowsky collaborates with scholars based in Denmark, United Kingdom and Netherlands. P Dombernowsky's co-authors include Heine H. Hansen, M Hansen, Kell Østerlind, György Sölétormos, Dorte Nielsen, Benny Vittrup Jensen, Torben Skovsgaard, Nis I. Nissen, Henning T. Mouridsen and Malgorzata Tuxen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

P Dombernowsky

190 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Dombernowsky Denmark	45	4.4k	2.1k	1.6k	1.4k	1.3k	195	6.7k
Geoffrey Falkson South Africa	43	3.4k 0.8×	2.0k 1.0×	915 0.6×	509 0.4×	2.0k 1.6×	264	6.8k
Scott Wadler United States	43	4.5k 1.0×	1.9k 0.9×	2.0k 1.3×	517 0.4×	610 0.5×	192	8.1k
Anthony Elias United States	50	5.9k 1.3×	3.5k 1.7×	2.2k 1.4×	520 0.4×	2.0k 1.6×	205	9.8k
Sewa S. Legha United States	46	4.0k 0.9×	1.1k 0.5×	1.7k 1.1×	465 0.3×	737 0.6×	138	6.4k
H. Cortés-Funes Spain	44	6.4k 1.5×	2.6k 1.3×	1.8k 1.2×	516 0.4×	1.3k 1.1×	192	9.6k
Ashley E. Winkler United States	10	3.9k 0.9×	2.5k 1.2×	1.1k 0.7×	731 0.5×	848 0.7×	12	7.3k
Scot C. Remick United States	38	2.8k 0.6×	1.0k 0.5×	1.5k 1.0×	781 0.6×	559 0.4×	156	6.1k
Frankie A. Holmes United States	42	6.7k 1.5×	1.3k 0.6×	1.6k 1.0×	354 0.3×	3.1k 2.5×	135	9.0k
Louise B. Grochow United States	32	4.0k 0.9×	1.5k 0.7×	1.3k 0.8×	786 0.6×	646 0.5×	59	6.6k
Patricia Keegan United States	54	5.0k 1.1×	3.1k 1.5×	2.1k 1.3×	790 0.6×	1.6k 1.3×	140	9.3k

Countries citing papers authored by P Dombernowsky

Since Specialization

Citations

This map shows the geographic impact of P Dombernowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Dombernowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Dombernowsky more than expected).

Fields of papers citing papers by P Dombernowsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Dombernowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Dombernowsky. The network helps show where P Dombernowsky may publish in the future.

Co-authorship network of co-authors of P Dombernowsky

This figure shows the co-authorship network connecting the top 25 collaborators of P Dombernowsky. A scholar is included among the top collaborators of P Dombernowsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Dombernowsky. P Dombernowsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, Carsten, Claus Kamby, Henning T. Mouridsen, et al.. (2000). Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age. Breast Cancer Research and Treatment. 61(2). 103–110. 16 indexed citations

Sigsgaard, Torben, Jørn Herrstedt, Poul Christensen, Ole Andersen, & P Dombernowsky. (2000). Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D 2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy. Supportive Care in Cancer. 8(3). 233–237. 15 indexed citations

Lassen, Ulrik, Kell Østerlind, Fred R. Hirsch, et al.. (1999). Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression. British Journal of Cancer. 79(3-4). 515–519. 31 indexed citations

Andersson, Michael, Ebbe Lindegaard Madsen, Marie Overgaard, et al.. (1999). Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group. European Journal of Cancer. 35(1). 39–46. 22 indexed citations

Sørensen, Jonas, Lars Stenbygaard, P Dombernowsky, & Heine H. Hansen. (1999). Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer. Annals of Oncology. 10(9). 1043–1050. 26 indexed citations

Ryberg, M., Dorte Nielsen, Torben Skovsgaard, et al.. (1998). Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.. Journal of Clinical Oncology. 16(11). 3502–3508. 223 indexed citations

Lassen, Ulrik, Kell Østerlind, M Hansen, et al.. (1995). Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.. Journal of Clinical Oncology. 13(5). 1215–1220. 209 indexed citations

Nielsen, Dorte, Vibeke Schiøler, Torben Skovsgaard, et al.. (1993). A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA. Annals of Oncology. 4(10). 861–869. 22 indexed citations

Oturai, Peter, Niels Henrik Holländer, Ole Hansen, et al.. (1993). Ceftriaxone versus latamoxef in febrile neutropenic patients: Empirical monotherapy in patients with solid tumours. European Journal of Cancer. 29(9). 1274–1279. 6 indexed citations

10.

Pedersen-Bjergaard, J, Torben Sigsgaard, Dorte Nielsen, et al.. (1992). Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.. Journal of Clinical Oncology. 10(9). 1444–1451. 99 indexed citations

11.

Nielsen, Dorte, et al.. (1992). Original article: Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy. Annals of Oncology. 3(5). 377–378. 7 indexed citations

12.

Bach, Flemming W., Niels Agerlin, Jens Benn Sørensen, et al.. (1992). Metastatic spinal cord compression secondary to lung cancer.. Journal of Clinical Oncology. 10(11). 1781–1787. 44 indexed citations

13.

Ck, Axelsson, et al.. (1991). [Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1].. PubMed. 153(33). 2270–2. 1 indexed citations

14.

Østerlind, Kell, M Hansen, Fred R. Hirsch, et al.. (1991). Combination chemotheraphy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens. Annals of Oncology. 2(1). 41–46. 11 indexed citations

15.

Bork, E, Jens Ersbøll, P Dombernowsky, et al.. (1991). Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.. Journal of Clinical Oncology. 9(9). 1627–1631. 42 indexed citations

16.

Herrstedt, Jørn, et al.. (1991). Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801). Annals of Oncology. 2(2). 154–155. 6 indexed citations

17.

Schütte, J., Henning T. Mouridsen, Wendy A. Stewart, et al.. (1990). Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 26(5). 558–561. 74 indexed citations

18.

Nielsen, Dorte, Jørgen Bjerggaard Jensen, P Dombernowsky, et al.. (1990). Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.. Journal of Clinical Oncology. 8(11). 1806–1810. 84 indexed citations

19.

Havsteen, Hanne, et al.. (1989). Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 23(2). 101–4. 8 indexed citations

20.

Thomsen, Henrik S., et al.. (1987). Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy. European Journal of Cancer and Clinical Oncology. 23(6). 779–781. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact